BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33217081)

  • 1. Vaccine-induced protection against hepatitis B in pediatric solid organ transplant patients.
    Ball M; Liverman R; Serluco A; Yildirim I
    Pediatr Transplant; 2021 May; 25(3):e13920. PubMed ID: 33217081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Durability of the hepatitis B vaccination in pediatric renal transplant recipients.
    Miller-Handley H; Paulsen G; Hooper DK; Lake M; Lazear D; Danziger-Isakov L
    Clin Transplant; 2018 May; 32(5):e13247. PubMed ID: 29603431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors Affecting the Development of an Antibody Response to Hepatitis B Immunization in Children With Intestinal Failure: Before and After Small Bowel Transplantation (With and Without Liver Graft).
    Craggs HM; Jackson P; Gupte G; Hartley J; Abdel-Hady M; Morton R; Beath S; Hogg L
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):1030-1036. PubMed ID: 26962060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessing vaccine-induced immunity against pneumococcus, hepatitis A and B over a 9-year follow-up in pediatric liver transplant recipients: A nationwide retrospective study.
    Gold T; Gualtieri R; Posfay-Barbe K; Wildhaber BE; McLin V; Blanchard-Rohner G
    Am J Transplant; 2024 Jun; 24(6):1070-1079. PubMed ID: 38103788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B and C serologic profiles of Canadian organ donors and recipients: retrospective 10-year review at a single center.
    Burton CE; Doucette KE; Mabilangan CA; Plitt SS; Lee BE; Preiksaitis JK
    Transpl Infect Dis; 2016 Aug; 18(4):520-8. PubMed ID: 27226204
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of hepatitis B virus antibody titers in childhood cancer survivors.
    Fayea NY; Kandil SM; Boujettif K; Fouda AE
    Eur J Pediatr; 2017 Sep; 176(9):1269-1273. PubMed ID: 28730317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B Virus Vaccination in HIV: Immunogenicity and Persistence of Seroprotection up to 7 Years Following a Primary Immunization Course.
    Nicolini LA; Magne F; Signori A; Di Biagio A; Sticchi L; Paganino C; Durando P; Viscoli C
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):922-928. PubMed ID: 29926738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in hepatitis B virus antibody titers over time among children: a single center study from 2012 to 2015 in an urban of South Korea.
    Lee KH; Shim KS; Lim IS; Chae SA; Yun SW; Lee NM; Choi YB; Yi DY
    BMC Pediatr; 2017 Jul; 17(1):164. PubMed ID: 28705230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. De novo hepatitis b prophylaxis with hepatitis B virus vaccine and hepatitis B immunoglobulin in pediatric recipients of core antibody-positive livers.
    Lee S; Kim JM; Choi GS; Park JB; Kwon CH; Choe YH; Joh JW; Lee SK
    Liver Transpl; 2016 Feb; 22(2):247-51. PubMed ID: 26600319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of active immunization in the prevention of de novo hepatitis B virus infection after pediatric liver transplantation with HBcAb positive donor liver].
    Cui Y; Lu W; Gao W; Dong C; Han C; Liu Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Oct; 29(10):926-930. PubMed ID: 29017655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccination in heart transplant candidates.
    Foster WQ; Murphy A; Vega DJ; Smith AL; Hott BJ; Book WM
    J Heart Lung Transplant; 2006 Jan; 25(1):106-9. PubMed ID: 16399538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis B virus (HBV) reverse seroconversion (RS) can be prevented even in non-responders to hepatitis B vaccine after allogeneic stem cell transplantation: long-term analysis of intervention in RS with vaccine for patients with previous HBV infection.
    Takahata M; Hashino S; Onozawa M; Shigematsu A; Sugita J; Fujimoto K; Endo T; Kondo T; Tanaka J; Imamura M; Teshima T
    Transpl Infect Dis; 2014 Oct; 16(5):797-801. PubMed ID: 25154638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allografted recipients immunized against hepatitis B virus are at high risk of gradual surface antibody (HbsAb) disappearance post transplant, regardless of adoptive immunity transfer.
    Kaloyannidis P; Batsis I; Yannaki E; Adamidou D; Bartzoudis D; Papathanasiou M; Mallouri D; Sakellari I; Fassas A; Anagnostopoulos A
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1049-56. PubMed ID: 17697967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease.
    Pratt PK; Nunes D; Long MT; Farraye FA
    Dig Dis Sci; 2019 Jul; 64(7):2031-2038. PubMed ID: 30945037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Considerable decrease in antibodies against hepatitis B surface antigen following kidney transplantation.
    Moal V; Motte A; Vacher-Coponat H; Tamalet C; Berland Y; Colson P
    J Clin Virol; 2015 Jul; 68():32-6. PubMed ID: 26071332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of hepatitis B nonimmunity in vaccinated pediatric liver transplant recipients.
    Leung DH; Ton-That M; Economides JM; Healy CM
    Am J Transplant; 2015 Feb; 15(2):535-40. PubMed ID: 25611886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased immune response to hepatitis B eight years after routine vaccination in Israel.
    Gold Y; Somech R; Mandel D; Peled Y; Reif S
    Acta Paediatr; 2003 Oct; 92(10):1158-62. PubMed ID: 14632331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.